Scailyte’s artificial intelligence-powered platform, ScaiVision, identifies disease signatures that predict drug efficacy and describe drug mode of action to improve clinical outcomes for patients with complex diseases.
Continue readingScailyte’s ScaiVision performs best-in-class at sample class prediction
ScaiVision performs as the best-in-class algorithm at identifying molecular biomarkers, which accurately predict clinical status of the samples. Analysis with ScaiVision unlocks an unparalleled level of high-resolution and clinically relevant discoveries in single-cell datasets.
Continue reading